Efficacy and Safety of Lenalidomide Plus CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma
Status:
Recruiting
Trial end date:
2026-12-31
Target enrollment:
Participant gender:
Summary
This study aims to compare the efficacy and safety of lenalidomide plus CHOP (L-CHOP) versus
CHOP alone in patients with previously untreated peripheral T-cell lymphoma (PTCL)
Phase:
Phase 2
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Collaborators:
Changhai Hospital First Affiliated Hospital of Harbin Medical University First Affiliated Hospital Xi'an Jiaotong University First Hospital of China Medical University Henan Provincial People's Hospital Huashan Hospital Hunan Cancer Hospital Jilin Provincial Tumor Hospital RenJi Hospital Ruijin Hospital Shandong Provincial Hospital Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Shanxi Province Cancer Hospital Southern Medical University, China The Affiliated Hospital of Xuzhou Medical University The First Affiliated Hospital of Anhui Medical University The First Affiliated Hospital of Dalian Medical University Union hospital of Fujian Medical University Wuhan Union Hospital, China Xiangya Hospital of Central South University Xinhua Hospital, Shanghai Jiao Tong University School of Medicine Xinqiao Hospital of Chongqing Zhongda Hospital Zhongshan Hospital Xiamen University